We would love to hear your thoughts about our site and services, please take our survey here.
IF 130p holds or hopefully moves on, there is the real prospect of a weekly ‘key reversal’. Those who are familiar with technical analysis, will know that this is both a rare and very bullish signal.
Today’s RNS certainly supports this scenario; fill yer boots!
Paul’s interview with Alastair is simply mind blowing. It is a must listen for all shareholders especially weak and sceptical holders.
Doubt that any institution is going pick up any significant quantity of shares without bidding up by a major percentage.
Interesting:-
https://www.telegraph.co.uk/news/2023/08/02/new-cancer-drug-aoh1996-may-annihilate-solid-tumours-study/.
Yep, 80/85p looks a reasonable medium term target on my view of the chart.
I am surprised no one has picked up on the negative AZN news about its new cancer drug, Dato-DXd. This caused a 8% fall in the AZN share price of several Bn £s, many, many times the capitalisation of AVCT.
Could AZN go ‘shopping’ elsewhere for a much cheaper route to solving their problems? They could easily afford a cheap bid for AVCT.
See http://digitaleditions.telegraph.co.uk/data/1350/reader/reader.html?social#!preferred/0/package/1350/pub/1350/page/94/article/NaN
Why don’t you shut up you complete and utter idiot.
Anyone with a brain can see that this is a one way bet. Finance houses will be all over it to offer support at virtually any price.
Dream on, sunshine
No, ex-rights date has been changed as the admission date is now 2 June and not 30 May.
Let’s now speculate on the outcome of success in the action against the Republic of Kosovo. The claim is for €195m which has undoubtedly been ‘kitchen sinked’.
FOX will shortly no doubt be funding the litigation by way of a CFA or DBA deal and we should therefore assume that anywhere between 30 and 50 ( at the extreme) percentage goes from any settlement. Then there are the original litigation funders who take a max of £1.75m.
For the sake of illustration, let’s assume a deal is done equal to £25m which would reduce to £13.25m IF a 40% contingency fee is taken. This would equal 3.17p per share pre the reorganisation. An extra £10m on the deal would add another 1.44p and the opposite if only £15m were achieved.
It is notoriously difficult to judge the possible outcomes of litigation but the upside for shareholders on the register before the cut-off look attractive relative to the current SP IF the company wins the case.
The shares will start trading next week based on the OLD price as the share consolidation etc will be the subject of a resolution at the EGM along with the other matters to be approved. I can assure you is the case based on my legal knowledge.
Agreed, very strange SP should be languishing given the obvious and significant potential the company has before it. I suppose HC have taken advantage of recent mild strengthening to offload some which has had an impact.
However, my main concern is why the directors seem to have so little interest in buying shares. OK there will have been periods when the rules would have prevented dealing but surely there have been many good chances to buy on the dips? Is this just the ‘boffin’ mentality of most of those on the board? Very puzzling.
I return to my comment, yes, I believe the SD was a fiasco. The day was specifically targeted at IIs and analysts and the reasonable expectation following the presentations on that day is that we would have seen strong buying from this cohort; we clearly have not. Are they baffled by the science or not convinced or what? Or is it simply that UK institutions are no longer interested in backing world beating technology?
As RAH said, Awful comms, genius science. The problem is that Avacta is being lead by a scientist not a serious businessman. All credit to Smith for getting us to where we are but if he is not very careful he is going to make a complete boxxocks of its financial potential. Most very successful companies are lead by a forceful and experienced businessman but in Dr Forster as chairman we have in reality yet another scientist. This needs to change and soon so that the fiasco of the science day is not repeated.